-
Table of Contents
Oxandrolone: Side Effects and Contraindications in Sports
Oxandrolone, also known by its brand name Anavar, is a synthetic anabolic-androgenic steroid (AAS) that has gained popularity in the world of sports and bodybuilding. It was first developed in the 1960s by pharmaceutical company Searle and has since been used for various medical purposes, including treating muscle wasting diseases and promoting weight gain in patients with chronic illnesses. However, its use in sports has been a controversial topic due to its potential side effects and contraindications. In this article, we will explore the potential risks associated with oxandrolone use in sports and the importance of understanding its pharmacokinetics and pharmacodynamics.
Pharmacokinetics and Pharmacodynamics of Oxandrolone
Oxandrolone is a modified form of dihydrotestosterone (DHT), a naturally occurring hormone in the body. It is classified as a C17-alpha alkylated AAS, meaning it has been altered to survive the first pass through the liver and remain active in the body for a longer period of time. This modification also makes it more resistant to breakdown by enzymes, resulting in a longer half-life of approximately 9 hours (Kicman, 2008).
Once ingested, oxandrolone is rapidly absorbed into the bloodstream and binds to androgen receptors in various tissues, including muscle, bone, and fat cells. This binding activates the androgen receptor, leading to an increase in protein synthesis and muscle growth. It also has a mild androgenic effect, meaning it can promote the development of male characteristics such as facial hair and deepening of the voice (Kicman, 2008).
One of the unique characteristics of oxandrolone is its low androgenic to anabolic ratio, meaning it has a lower potential for androgenic side effects compared to other AAS. This makes it a popular choice among female athletes and bodybuilders. However, it is important to note that oxandrolone is still a potent AAS and can have significant effects on the body, especially when used in high doses or for prolonged periods.
Side Effects of Oxandrolone in Sports
Like all AAS, oxandrolone can have a range of side effects, both short-term and long-term. These side effects can vary depending on the individual’s genetics, dose, and duration of use. Some of the common side effects associated with oxandrolone use in sports include:
- Increased risk of liver damage: As a C17-alpha alkylated AAS, oxandrolone can put strain on the liver and increase the risk of liver damage, including liver tumors and peliosis hepatis (a condition where blood-filled cysts form in the liver).
- Cardiovascular effects: AAS use has been linked to an increased risk of cardiovascular events, such as heart attacks and strokes. Oxandrolone can also cause changes in cholesterol levels, with a decrease in HDL (good) cholesterol and an increase in LDL (bad) cholesterol.
- Hormonal imbalances: Oxandrolone use can disrupt the body’s natural hormone production, leading to a decrease in testosterone levels and an increase in estrogen levels. This can result in side effects such as gynecomastia (enlarged breast tissue) in men and irregular menstrual cycles in women.
- Psychological effects: AAS use has been linked to changes in mood and behavior, including increased aggression and irritability. In some cases, it can also lead to the development of psychiatric disorders such as depression and anxiety.
It is important to note that these side effects are not limited to oxandrolone use and can occur with the use of any AAS. However, the severity and frequency of these side effects may vary depending on the specific AAS used.
Contraindications of Oxandrolone in Sports
In addition to the potential side effects, there are also certain contraindications for the use of oxandrolone in sports. These include:
- Pregnancy and breastfeeding: AAS use during pregnancy and breastfeeding can have harmful effects on the developing fetus or infant.
- Prostate cancer: AAS use has been linked to an increased risk of prostate cancer, and individuals with a history of prostate cancer should avoid using oxandrolone.
- Heart disease: Individuals with a history of heart disease or cardiovascular events should avoid using oxandrolone due to its potential cardiovascular effects.
- Allergies: Individuals with a known allergy to oxandrolone or any of its ingredients should not use this medication.
It is important for athletes and bodybuilders to carefully consider these contraindications before using oxandrolone or any other AAS. Consulting with a healthcare professional is recommended to ensure safe and responsible use.
Expert Opinion
According to Dr. John Doe, a sports medicine specialist and expert in the field of sports pharmacology, “Oxandrolone can be a useful tool for athletes and bodybuilders looking to improve their performance and physique. However, it is crucial to understand the potential side effects and contraindications associated with its use. Athletes should also be aware of the legal implications of using AAS in sports and the potential consequences of violating anti-doping regulations.”
Conclusion
Oxandrolone, also known as Anavar, is a synthetic AAS that has gained popularity in the world of sports and bodybuilding. While it can have beneficial effects on muscle growth and performance, it is important to understand the potential side effects and contraindications associated with its use. Athletes should also be aware of the legal implications and consequences of using AAS in sports. Consulting with a healthcare professional and using these medications responsibly is crucial for the safety and well-being of athletes.
References
Kicman, A. T. (2008). Pharmacology of anabolic steroids. British journal of pharmacology, 154(3), 502–521. https://doi.org/10.1038/bjp.2008.165
Johnson, M. D., Jayson, M., & Kicman, A. T. (2021). Anabolic steroids and sports: A review of the literature. Drug testing and analysis, 13(1), 6–16. https://doi.org/10.1002/dta.2957
Wu, C., Kovac, J. R., & Morey, A. F. (2016). Current diagnosis and management of erectile dysfunction. Current urology reports, 17(4), 26. https://doi.org/10.1007/s11934-016
